Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	GLPG1972 75 mg	234
Overall Study	STARTED	GLPG1972 150 mg	231
Overall Study	STARTED	GLPG1972 300 mg	233
Overall Study	STARTED	Placebo	234
Overall Study	Treated	GLPG1972 75 mg	234
Overall Study	Treated	GLPG1972 150 mg	231
Overall Study	Treated	GLPG1972 300 mg	232
Overall Study	Treated	Placebo	234
Overall Study	COMPLETED	GLPG1972 75 mg	191
Overall Study	COMPLETED	GLPG1972 150 mg	191
Overall Study	COMPLETED	GLPG1972 300 mg	177
Overall Study	COMPLETED	Placebo	200
Overall Study	NOT COMPLETED	GLPG1972 75 mg	43
Overall Study	NOT COMPLETED	GLPG1972 150 mg	40
Overall Study	NOT COMPLETED	GLPG1972 300 mg	56
Overall Study	NOT COMPLETED	Placebo	34

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03595618/flow